JWS
ALXN

Juncture Wealth Strategies’s Alexion Pharmaceuticals ALXN Stock Holding History

Juncture Wealth Strategies’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,102
Closed -$328K – 126
2020
Q4 		$328K Buy
2,102
+236
+13% +$30.3K 0.21% 91
2020
Q3 		$214K Sell
1,866
-235
-11% -$25.4K 0.15% 96
2020
Q2 		$236K Buy
+2,101
New +$223K 0.18% 94
2020
Q1 		– Sell
-2,455
Closed -$266K – 104
2019
Q4 		$266K Sell
2,455
-790
-24% -$84.5K 0.21% 91
2019
Q3 		$318K Sell
3,245
-161
-5% -$18.1K 0.28% 81
2019
Q2 		$446K Sell
3,406
-200
-6% -$25.8K 0.36% 76
2019
Q1 		$487K Buy
+3,606
New +$448K 0.38% 73
2017
Q2 		– Sell
-2,406
Closed -$292K – 86
2017
Q1 		$292K Sell
2,406
-89
-4% -$11.5K 0.18% 73
2016
Q4 		$305K Sell
2,495
-1,810
-42% -$221K 0.21% 74
2016
Q3 		$528K Sell
4,305
-690
-14% -$88.8K 0.36% 61
2016
Q2 		$583K Sell
4,995
-130
-3% -$18.4K 0.42% 58
2016
Q1 		$714K Sell
5,125
-514
-9% -$75.5K 0.53% 50
2015
Q4 		$1.08M Buy
5,639
+265
+5% +$46.3K 0.8% 28
2015
Q3 		$840K Buy
5,374
+1,475
+38% +$269K 0.68% 36
2015
Q2 		$705K Buy
3,899
+133
+4% +$23K 0.57% 41
2015
Q1 		$653K Sell
3,766
-3,548
-49% -$642K 0.54% 44
2014
Q4 		$1.36M Buy
+7,314
New +$1.36M 0.65% 41

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Juncture Wealth Strategies's ALXN Position: Q1 2021 in Review

Juncture Wealth Strategies sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 2,102 shares — an estimated $328K sold.

Juncture Wealth Strategies first reported a position in ALXN in Q4 2014 and held it in 17 quarters. The position peaked at $1.36M in Q4 2014. 752 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

  • Juncture Wealth Strategies reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Juncture Wealth Strategies sold 2,102 Alexion Pharmaceuticals shares in Q1 2021, an estimated $328K.
  • Juncture Wealth Strategies first reported a position in Alexion Pharmaceuticals in Q4 2014 and held it in 17 quarters.
  • Juncture Wealth Strategies's Alexion Pharmaceuticals position peaked at $1.36M in Q4 2014.
  • 752 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on Juncture Wealth Strategies's 13F filing for Q1 2021, filed 15 Apr 2021.